Shilaih, Mohaned
Marzel, Alex
Yang, Wan Lin
Scherrer, Alexandra U.
Schüpbach, Jörg
Böni, Jürg
Yerly, Sabine
Hirsch, Hans H.
Aubert, Vincent
Cavassini, Matthias
Klimkait, Thomas
Vernazza, Pietro L.
Bernasconi, Enos
Furrer, Hansjakob
Günthard, Huldrych F.
Kouyos, Roger
Battegay, Manuel
Braun, Dominique
Bucher, Heiner
Burton-Jeangros, Claudine
Calmy, Alexandra
Dollenmaier, Günter
Egger, Matthias
Elzi, Luigia
Fehr, Jan
Fellay, Jaque
Fux, Christoph
Gorgievski, Meri
Haerry, David
Hasse, Barbara
Hoffmann, Matthias
Hösli, Irene
Kahlert, Christian
Kaiser, Laurent
Keiser, Olivia
Kovari, Helen
Ledergerber, Bruno
Martinetti, Gladys
de Tejada, Begoña Martinez
Marzolini, Catia
Metzner, Karin
Müller, Nicolas
Nadal, David
Nicca, Dunja
Pantaleo, Giuseppe
Rauch, Andre
Regenass, Stephan
Rudin, Christoph
Schöni-Affolter, Franziska
Schmid, Patrick
Speck, Roberto
Stöckle, Marcel
Tarr, Philip
Trkola, Alexandra
Weber, Reiner
,
Article History
Received: 23 December 2015
Accepted: 17 May 2016
First Online: 14 June 2016
Competing interests
: H.F.G. has been an adviser and/or consultant for the following companies: GlaxoSmithKline, Abbott, Gilead, Novartis, Boehringer Ingelheim, Roche, Tibotec, Pfizer and Bristol-Myers Squibb, and has received unrestricted research and educational grants from Roche, Abbott, Bristol-Myers Squibb, Gilead, Astra-Zeneca, GlaxoSmithKline, and Merck Sharp & Dohme (all money went to institution). RDK received travel grants from Gilead.